Nurulimab (Anti-CTLA-4 / CD152)
Product Specifications
CAS Number
2168561-20-2
Target
Immunology & Inflammation related
Applications
Immunology & Inflammation
Additionnal Information
Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![4-(Piperazin-1-yl)thieno[3,2-c]pyridine Dihydrochloride](https://cdn.genprice.uk/products/572/315672720959/imageurl/trc-p482543-10mg.webp)
TRC-P482543-10MG 10 mg
4-(Piperazin-1-yl)thieno[3,2-c]pyridine Dihydrochloride
Sign In for Pricing
View Details 
